Influence of diabetes on susceptibility to experimental pancreatic cancer

The American Journal of Surgery

Volumn 155, Issue 1, 1988, Pages 159-164

  Bell Jr , Richard H ^a   McCullough, Patrick J ^a   Pour, Parviz M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; DIABETES MELLITUS; HAMSTER; NONHUMAN; PANCREAS CANCER;

ANIMAL; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE SUSCEPTIBILITY; HAMSTERS; MALE; MESOCRICETUS; NIACINAMIDE; NITROSAMINES; PANCREATIC NEOPLASMS; STREPTOZOCIN; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0023835413     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(88)80274-5     Document Type: Article

References (17)

1. Cancer statistics
2. Cancer mortality among diabetics
3. Diabetic mortality in Australia
4. The association of diabetes mellitus with primary carcinoma of the pancreas
5. Diabetes and cancer
6. Carcinoma of the pancreas
7. A prospective study of glucose tolerance insulin C-peptide and glucagon responses in patients with pancreatic carcinoma
8. A case control study of cancer of the pancreas
9. Cancers of the pancreas and biliary tract: epidemiological considerations
10. Cancer of the pancreas induced in the Syrian golden hamster
11. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)-amine
12. Ductular origin of pancreatic cancer and its multiplicity in man comparable to experimentally induced tumors. A preliminary study
13. Streptozotocin prevents development of nitrosamine-induced pancreatic cancer in the Syrian hamster
14. Animal models of diabetes mellitus: physiology and pathology
15. Streptozotocin diabetes: further studies of the mechanisms of depression of nicotinamide adenine dinucleotide concentration in mouse pancreaticislets and liver
16. Streptozotocin-induced liver tumors in the Syrian hamster
17. Plasma insulin in health and disease